Positive

Aug 26, 2025, 06:32

Cancer Vaccines Bring Hope of a New Era in Cancer Prevention and Treatment – UICC

Union for International Cancer Control (UICC) shared a post on LinkedIn:

“Once considered a distant goal, cancer vaccines are now moving closer to becoming reality.

LungVax – backed by Cancer Research UK (CRUK), a UICC member, and the CRIS Foundation – will begin trials in 2026, testing mRNA technology on 3,000 high-risk participants aged 55 – 74.
Therapeutic vaccines for melanoma and HPV-related head and neck cancers are in advanced trials, with the potential to become NHS treatments in the UK within five years.

While challenges remain, from production costs and logistics, to long-term tracking of personalised approaches – these breakthroughs bring hope of a new era in cancer prevention and treatment.

Read more in our latest article.”

UICC

More posts featuring Union for International Cancer Control on OncoDaily.

cancer Cancer Research UK (CRUK) cancer vaccines CRIS Foundation HPV-related head and neck cancers LungVax OncoDaily Oncology UICC Union for International Cancer Control

Padraic O’Malley: Meet the Experts of VIRO 2025

Hidden Risks: BRCA Mutations and Breast Implants - CancerWorld

FDA Breakthrough Therapy Designation for Iza-bren: Advancing Treatment for EGFR-Mutant NSCLC

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Author?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen